<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01979926</url>
  </required_header>
  <id_info>
    <org_study_id>PMK-N02RS1</org_study_id>
    <nct_id>NCT01979926</nct_id>
  </id_info>
  <brief_title>Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis</brief_title>
  <official_title>Double-blind, A Multicenter, Randomized, Placebo-controlled, Parallel, Phase 2 Study to Comparative Evaluate the Efficacy of N02RS1 600mg/Day, 12,00mg/Day in Korean Patients With Acute and Chronic Bronchitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PharmaKing</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PharmaKing</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the
      Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With
      acute and acute exacerbation of chronic bronchitis for 7 days.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>12weeks</time_frame>
    <description>1.Adverse Event: symptom, start day and time, end day and time, injection time, severity, progress, outcome, relation with investigational product.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy</measure>
    <time_frame>12weeks</time_frame>
    <description>Before and after physical examination
Before and after bital Sign: blood pressure, pulse rate, temperature.
Before and after Lanza Score at the duodenum and stomach
Lab: hematologic examination, blood coagulation examination,urine examination
Cumulative incidence rate of an endoscopic peptic ulcer.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Acute Exacerbation of Chronic Bronchitis</condition>
  <arm_group>
    <arm_group_label>N02RS1 200mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of Broussonetia spp and Lonicera spp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N02RS1 400mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of Broussonetia spp and Lonicera spp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sugar pill</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combination of Broussonetia spp and Lonicera spp</intervention_name>
    <description>600 mg/ day or 1200 mg/ day for 7 days</description>
    <arm_group_label>N02RS1 200mg</arm_group_label>
    <arm_group_label>N02RS1 400mg</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>N02RS1</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18, under 75 years of age

          -  Patients Acute and Chronic Bronchitis

        Exclusion Criteria:

          -  Patients who have gotten a glucocorticoids treatment within 4 weeks.

          -  Patients who need treatments of antibiotic and acute bronchitis infection.

          -  Patients who have gotten teatments of antibiotic,bronchodilator,painkiller and
             secretagog within 7 days.

          -  Bronchial asthma patient.

          -  Patients who have an indication of bleeding.

          -  Patients who have a serious heart and renal disease or liver ailment or
             immunosuppressive response.

          -  Patients who have history of over 3 phage of Chronic obstructiv lung disease

          -  Bronchiectasis patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wayne B An, Bs</last_name>
    <role>Study Director</role>
    <affiliation>Korea Pharmaceutical Manufacturers Association</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul Nat'l University of Boramae Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>November 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2013</study_first_posted>
  <last_update_submitted>May 29, 2014</last_update_submitted>
  <last_update_submitted_qc>May 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Acute Disease</mesh_term>
    <mesh_term>Bronchitis, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

